Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Schrama

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|January 9, 2007
[The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed]E Schrama, J P Eusman
Blood|August 26, 1998
CD80-Transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigensT Mutis, E Schrama, C J Melief, et al.
Blood|March 26, 1999
Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigensT Mutis, R Verdijk, E Schrama, et al.
European Heart Journal|April 5, 2001
New normal limits for the paediatric electrocardiogramP R Rijnbeek, M Witsenburg, E Schrama, et al.
Nature Medicine|July 8, 1999
Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host diseaseT Mutis, G Gillespie, E Schrama, et al.
Transplant Immunology|December 1, 1994
The role of unconventional alloantigens in interstitial and vascular rejection after renal transplantationF J van der Woude, E Schrama, L A van Es, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligandG Gillespie, T Mutis, E Schrama, et al.
Blood|August 1, 1997
HLA class II restricted T-cell reactivity to a developmentally regulated antigen shared by leukemic cells and CD34+ early progenitor cellsT Mutis, E Schrama, S A van Luxemburg-Heijs, et al.
Scandinavian Journal of Rheumatology|January 1, 1990
Value of anti-neutrophil cytoplasmic autoantibodies and other laboratory parameters in follow-up of vasculitisC Halma, M R Daha, E Schrama, et al.
The Netherlands Journal of Medicine|April 1, 1990
Isolation from purulent sputum of an antigen reactive with antibodies in serum of patients with Wegener's granulomatosisM R Daha, J Leusen, J A Kramps, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|January 9, 2007
[The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed]E Schrama, J P Eusman
Blood|August 26, 1998
CD80-Transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigensT Mutis, E Schrama, C J Melief, et al.
Blood|March 26, 1999
Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigensT Mutis, R Verdijk, E Schrama, et al.
European Heart Journal|April 5, 2001
New normal limits for the paediatric electrocardiogramP R Rijnbeek, M Witsenburg, E Schrama, et al.
Nature Medicine|July 8, 1999
Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host diseaseT Mutis, G Gillespie, E Schrama, et al.
Transplant Immunology|December 1, 1994
The role of unconventional alloantigens in interstitial and vascular rejection after renal transplantationF J van der Woude, E Schrama, L A van Es, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligandG Gillespie, T Mutis, E Schrama, et al.
Blood|August 1, 1997
HLA class II restricted T-cell reactivity to a developmentally regulated antigen shared by leukemic cells and CD34+ early progenitor cellsT Mutis, E Schrama, S A van Luxemburg-Heijs, et al.
Scandinavian Journal of Rheumatology|January 1, 1990
Value of anti-neutrophil cytoplasmic autoantibodies and other laboratory parameters in follow-up of vasculitisC Halma, M R Daha, E Schrama, et al.
The Netherlands Journal of Medicine|April 1, 1990
Isolation from purulent sputum of an antigen reactive with antibodies in serum of patients with Wegener's granulomatosisM R Daha, J Leusen, J A Kramps, et al.
Pageof 2